Publications

2008

Yang C, Lu P, Lee FY, Chadburn A, Barrientos JC, Leonard JP, et al. Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. Leukemia. 2008;22(9):1755-66.
Joshi J, Fernandez-Marcos PJ, Galvez A, Amanchy R, Linares JF, Duran A, et al. Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis. EMBO J. 2008;27(16):2181-93.
Magro CM, Schaefer JT, Waldman J, Knight D, Seilstad K, Hearne D. Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis. J Cutan Pathol. 2008;35(1):74-81.
Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen A-, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature. 2008;455(7216):1129-33.
Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, et al. Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. Am J Clin Pathol. 2008;130(6):957-62.
Martin P, Chadburn A, Christos P, Furman R, Ruan J, Joyce MA, et al. Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. Ann Oncol. 2008;19(7):1327-1330.
Ince TA, Ward JM, Valli VE, Sgroi D, Nikitin AY, Loda M, et al. Do-it-yourself (DIY) pathology. Nat Biotechnol. 2008;26(9):978-9; discussion 979.
Chen C-, Tyler J. Chromatin reassembly signals the end of DNA repair. Cell Cycle. 2008;7(24):3792-7.
Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, et al. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle. 2008;7(14):2257-67.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700